{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:32:22Z","timestamp":1786361542966,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction and importance:<\/jats:title>\n                    <jats:p>The coexistence of anti-glomerular basement membrane (anti-GBM) disease and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis represents a rare autoimmune overlap syndrome that poses significant diagnostic and therapeutic challenges. This dual-positive presentation is particularly uncommon in patients with pre-existing chronic kidney disease (CKD) and offers valuable insight into the complexities of disease overlap and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>We report a 48-year-old woman with known CKD who presented with acute pulmonary\u2013renal syndrome manifesting as dyspnea, productive cough, oliguria, and altered sensorium. Laboratory evaluation revealed markedly elevated serum urea and creatinine, raised inflammatory markers, and dual serologic positivity for anti-GBM and perinuclear ANCA (p-ANCA) antibodies, confirming dual-positive vasculitis. Serologic testing was initiated due to persistent respiratory distress and worsening renal function despite appropriate hemodialysis and empiric antibiotic therapy, prompting evaluation for an underlying autoimmune etiology. Testing was performed within the first 48\u00a0h of admission after failure of initial supportive measures to produce clinical improvement. The patient received urgent hemodialysis, high-dose intravenous corticosteroids followed by oral taper, plasmapheresis, and cyclophosphamide. Her neurological and respiratory symptoms improved gradually; however, dialysis dependence persisted due to underlying renal damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>Dual-positive anti-GBM and ANCA-associated vasculitis represents an uncommon but clinically significant overlap syndrome. The coexistence of both antibodies complicates diagnosis and management, especially in patients with CKD, where baseline renal dysfunction may mask active disease. Early recognition through serologic testing and prompt initiation of combined immunosuppressive and plasmapheresis therapy are critical to preventing irreversible organ injury. This case reinforces the importance of multidisciplinary management and long-term follow-up to monitor disease activity and prevent relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case highlights the need to consider dual-positive anti-GBM and ANCA-associated vasculitis in patients presenting with unexplained renal deterioration or pulmonary symptoms, even in the context of CKD. Timely diagnosis and individualized immunosuppressive therapy can improve outcomes and reduce irreversible organ damage in this rare overlap syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005076","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:04:42Z","timestamp":1778058282000},"page":"3709-3714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent anti-GBM disease and p-ANCA vasculitis presenting as pulmonary\u2013renal syndrome in a patient with chronic kidney disease: a case report"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1291-1422","authenticated-orcid":false,"given":"Rabia","family":"Nazeer","sequence":"first","affiliation":[{"name":"Department of Medicine, DG Khan Medical College, Dera Ghazi Khan, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9644-931X","authenticated-orcid":false,"given":"Muhammad Asher","family":"Nazir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gulab Devi Hospital, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4196-7694","authenticated-orcid":false,"given":"Bhavna","family":"Singla","sequence":"additional","affiliation":[{"name":"Internal Medicine, Erie County Medical Center (ECMC), Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6584-3590","authenticated-orcid":false,"given":"Shivam","family":"Singla","sequence":"additional","affiliation":[{"name":"Internal Medicine, Tidal Health Peninsula Regional\/Johns Hopkins Institute, Salisbury, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4850-4861","authenticated-orcid":false,"given":"Shabbir","family":"Mazari","sequence":"additional","affiliation":[{"name":"Internal Medicine, Kabul Medical University, Kabul, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"R1-20260810","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/jcm10071446","article-title":"ANCA-associated vasculitis: an update","volume":"10","author":"Almaani","year":"2021","journal-title":"J Clin Med"},{"key":"R2-20260810","first-page":"gfaf190","article-title":"Anti-glomerular basement membrane disease\u2014treatment standard","author":"McAdoo","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"R3-20260810","first-page":"141754","article-title":"Renal-limited anti-GBM disease in dual-antibody positive RPGN: a case report","volume":"4","author":"Guo","year":"2023","journal-title":"J Brown Hosp Med"},{"key":"R4-20260810","doi-asserted-by":"crossref","first-page":"1521\u201328","DOI":"10.1007\/s00296-024-05631-3","article-title":"Co-existence of ANCA-associated vasculitides with immune-mediated diseases: a single-center observational study","volume":"44","author":"Masiak","year":"2024","journal-title":"Rheumatol Int"},{"key":"R5-20260810","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence\u2014the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"810680","DOI":"10.3389\/fmed.2021.810680","article-title":"ANCA-associated vasculitis with anti-GBM disease and two types of tumors: a case report","volume":"8","author":"Li","year":"2022","journal-title":"Front Med"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"831\u201340","DOI":"10.1007\/s10067-019-04854-1","article-title":"Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study","volume":"39","author":"Yoo","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R8-20260810","first-page":"2495\u201398","article-title":"Beyond serology: is there still a value of kidney biopsy in anti-glomerular basement membrane disease?","volume":"8","author":"Ivkovi\u0107","year":"2023","journal-title":"Kidney Int Rep"},{"key":"R9-20260810","first-page":"614\u201318","article-title":"Rituximab for anti\u2013glomerular basement membrane disease","volume":"4","author":"Jain","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R10-20260810","doi-asserted-by":"crossref","first-page":"693\u2013702","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:00:40Z","timestamp":1786359640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005076","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}